A phase I/II study of 131I mIBG in chemo-resistant neuroblastoma. The United Kingdom Children's Cancer Study Group (UKCCSG).
Lewis
I J
IJ
Seacroft Hospital, Leeds.
Lashford
L S
LS
Fielding
S
S
Flower
M A
MA
Ackery
D
D
Kemshead
J
J
D019797:3-Iodobenzylguanidine; D000740:Anemia / Q000209:etiology; D000970:Antineoplastic Agents / Q000633:toxicity*; D002675:Child, Preschool; D004341:Drug Evaluation; D006801:Humans; D007457:Iodine Radioisotopes / Q000633:toxicity*; D007462:Iodobenzenes / Q000627:therapeutic use / Q000633:toxicity*; D009367:Neoplasm Staging; D009447:Neuroblastoma / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy*; D009503:Neutropenia / Q000209:etiology; D011832:Radiation Injuries / Q000209:etiology; D011877:Radionuclide Imaging; D013921:Thrombocytopenia / Q000209:etiology
D000970:Antineoplastic Agents; D007457:Iodine Radioisotopes; D007462:Iodobenzenes; D019797:3-Iodobenzylguanidine